Position in JNJ
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,237,087
+$6,332 QoQ
Shares Held
4,871
-3.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.41%
of 13F equity value
Holder Rank
#2,801
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Front Row Advisors LLC holds $11,088,191 across 9 Drug Manufacturers - General names. JNJ ranks #3 (11.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
24,207 | $6,091,449 | |
| 2 | AMGN |
Amgen Inc
|
8,625 | $3,123,285 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
4,871 | $1,237,087 | |
| 4 | LLY |
ELI LILLY & Co
|
287 | $344,236 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
1,497 | $189,130 | |
| 6 | PFE |
Pfizer Inc
|
2,210 | $53,216 | |
| 7 | MRK |
Merck & Co., Inc.
|
297 | $38,164 | |
| 8 | GSK |
GSK plc
|
221 | $11,584 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,237,087 | 4,871 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,230,755 | 5,035 | Shares | Sole | 2026-05-19 | |
| 2025-12-31 | $1,041,993 | 5,035 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $953,429 | 5,142 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $786,815 | 5,151 | Shares | Sole | 2025-08-18 | |
| 2025-03-31 | $1,016,765 | 6,131 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $981,102 | 6,784 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $1,117,565 | 6,896 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,394,804 | 9,543 | Shares | Sole | 2024-08-16 | |
| 2024-03-31 | $1,374,196 | 8,687 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,018,026 | 6,495 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $1,410,783 | 9,058 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $1,611,006 | 9,733 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $1,513,265 | 9,763 | Shares | Sole | 2023-05-23 | |
| 2022-12-31 | $1,776,922 | 10,059 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $1,642,258 | 10,053 | Shares | Sole | 2022-11-16 | |
| 2022-06-30 | $1,796,401 | 10,120 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,795,871 | 10,133 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $1,734,820 | 10,141 | Shares | Sole | 2022-03-09 | |
| 2021-09-30 | $1,641,001 | 10,161 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $1,673,923 | 10,161 | Shares | Sole | 2021-08-23 | |
| 2021-03-31 | $1,874,740 | 11,407 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $1,797,594 | 11,422 | Shares | Sole | 2021-02-25 | |
| 2020-09-30 | $1,700,507 | 11,422 | Shares | Sole | 2020-11-30 | |
| 2020-06-30 | $1,618,229 | 11,507 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $1,550,743 | 11,826 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||